Horizon Therapeutics PLC (HZNP): Price and Financial Metrics

HZNP POWR Grades

• Value is the dimension where HZNP ranks best; there it ranks ahead of 92.31% of US stocks.
• The strongest trend for HZNP is in Momentum, which has been heading up over the past 178 days.
• HZNP's current lowest rank is in the Momentum metric (where it is better than 24.4% of US stocks).

HZNP Stock Summary

• HORIZON THERAPEUTICS PUBLIC LTD CO's market capitalization of $17,569,962,181 is ahead of 88.94% of US-listed equities.
• With a one year PEG ratio of 141.89, HORIZON THERAPEUTICS PUBLIC LTD CO is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 84.18% of US stocks.
• HZNP's current price/earnings ratio is 30.6, which is higher than 78.27% of US stocks with positive earnings.
• Stocks that are quantitatively similar to HZNP, based on their financial statements, market capitalization, and price volatility, are TECH, APPS, MASI, OSIS, and PRLB.
• HZNP's SEC filings can be seen here. And to visit HORIZON THERAPEUTICS PUBLIC LTD CO's official web site, go to www.horizontherapeutics.com.

HZNP Valuation Summary

• In comparison to the median Healthcare stock, HZNP's price/sales ratio is 140% higher, now standing at 4.8.
• Over the past 138 months, HZNP's price/earnings ratio has gone up 34.8.

Below are key valuation metrics over time for HZNP.

HZNP Growth Metrics

Its 3 year price growth rate is now at 238.06%.
• Its year over year net income to common stockholders growth rate is now at 207.85%.
• The 2 year price growth rate now stands at 124.58%.

HZNP's revenue has moved up $2,401,450,000 over the prior 33 months.

The table below shows HZNP's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	3,701.479	1,370.008	574.256
2022-06-30	3,813.112	1,414.584	764.96
2022-03-31	3,769.249	1,254.79	862.103
2021-12-31	3,226.41	1,035.271	534.491
2021-09-30	2,957.26	906.531	551.866
2021-06-30	2,556.695	604.354	518.163

HZNP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HZNP has a Quality Grade of C, ranking ahead of 61.77% of graded US stocks.
• HZNP's asset turnover comes in at 0.385 -- ranking 123rd of 681 Pharmaceutical Products stocks.
• VNDA, NEOG, and CEMI are the stocks whose asset turnover ratios are most correlated with HZNP.

The table below shows HZNP's key quality metrics over time.